Di Huang

7PUBLICATIONS
32CO-AUTHORS
Tumour immunologyCancer therapy (excl. chemotherapy and radiation therapy)Cancer cell biologyMolecular targetsPredictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|Nov 11, 2025
Tumor-Derived CDC37 Inhibits Antigen Cross-Presentation in Dendritic Cells and Impairs Anti-Tumor Immunity in Breast Cancer.

Ruxin Wang, Yunyi Zhang, Xiangyu Meng

|Nov 12, 2024
Ferroptotic Neutrophils Induce Immunosuppression and Chemoresistance in Breast Cancer.

Wenfeng Zeng, Ruihua Zhang, Penghan Huang

|Mar 16, 2024
Activation of Bivalent Gene POU4F1 Promotes and Maintains Basal-like Breast Cancer.

Jiahui Zhang, Nanyan Miao, Liyan Lao

|Dec 13, 2023
Tumour circular RNAs elicit anti-tumour immunity by encoding cryptic peptides.

Di Huang, Xiaofeng Zhu, Shuying Ye

|Jan 05, 2023
CD8+ T cell-Dependent Remodeling of the Tumor Microenvironment Overcomes Chemoresistance.

Liyan Lao, Wenfeng Zeng, Penghan Huang

|Nov 23, 2022
CCL18 signaling from tumor-associated macrophages activates fibroblasts to adopt a chemoresistance-inducing phenotype.

Wenfeng Zeng, Lixiong Xiong, Wei Wu

Pageof 2

Frequent Collaborators

3 joint publications

Erwei Song

3 joint publications

Jianing Chen

2 joint publications

Shuying Ye

2 joint publications

Jiang Liu